Economic impact of the use of patiromer in chronic kidney disease or heart failure for the treatment of chronic hyperkalemia in Spain

1. de Sequera, P.
2. Bover, R.
3. Ivanova-Markova, Y.
4. Ivanova, A.
5. González-Domínguez, A.
6. Valls, M.
7. Campos, V.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.NEFROE.2024.01.002 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus